Centre Henri Becquerel

Recent papers from Centre Henri Becquerel

1. Spatial knowledge modelling for agent based systemJournal of Interdisciplinary Methodologies and Issues in Sciences · 2026
2. Prognostic Impact of FLT3 ‐ ITD Allelic Ratio in AML Patients Treated With High‐Dose Anthracycline and a FLT3 InhibitorAmerican Journal of Hematology · 2026
3. Outcomes of ibrutinib plus lenalidomide combination in patients with large Bcell lymphoma refractory to or relapsing after CAR-T-cell therapy and who failed or were ineligible for bispecific antibodies: a multicenter real-world REALI-T studyHaematologica · 2026
4. Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trialThe Lancet · 2025
5. Potential Benefit of Ruxolitinib in Suspected Ocular and Neurological Transplant‐Associated Thrombotic Microangiopathy After Allogeneic Stem Cell Transplantation: A Case Report and ReviewClinical Case Reports · 2026
6. Explaining educational differences in return to work after early breast cancer: a mediation analysis.2026
7. Research Study Attrition and Participant-Informed Retention Strategies Among Cancer SurvivorsJAMA Network Open · 2026
8. LymphGen-Sig: Integrating Genetic and Transcriptional States to Predict Therapeutic Response in Diffuse Large B-Cell LymphomaJournal of Clinical Oncology · 2026
9. Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin’s lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trialHaematologica · 2026
10. Cerebrospinal Fluid Circulating Tumor DNA Profiling in Central Nervous System Metastases from Solid Tumors: A Prospective Multicentre Translational Analysis of the BrainStorm (OncoDistinct-006) StudyThe Journal of Liquid Biopsy · 2026
11. Chemotherapy type and survival in young BRCA1/2 carriers with HER2-negative early breast cancerEuropean Journal of Cancer · 2026
12. PD-L2 is associated with lineage-related transcriptional programs distinct from PD-L1 in primary mediastinal large B-cell lymphomaLeukemia · 2026
13. MiT fusions, TSC1–TSC2 divergence, and stem-like programs reveal distinct origins and vulnerabilities in PEComaNature Communications · 2026
14. Reported practices and difficulties for preventing emerging highly resistant bacteria in hemodialysis: the PHYDEL survey2026
15. Chemotherapy-induced gut microbiota taxonomic deviation and its association with outcomes and toxicities in breast cancer: CANTO microbiota.Journal of Clinical Oncology · 2026
16. Baseline skeletal muscle index as an independent prognostic factor in locally advanced head and neck squamous cell carcinoma: A post hoc analysis of the REACH trial.Journal of Clinical Oncology · 2026
17. Phase 1/2a study of concomitant radiotherapy with olaparib and temozolomide in unresectable high-grade glioma patients: Final results from the phase 2a step (OLA-TMZ-RTE-01).Journal of Clinical Oncology · 2026
18. 68P Clinical value of Circulating Tumor Cells (CTC) in the phase III randomized AMBRE trial comparing chemotherapy (CT) vs endocrine therapy (ET) and Abemaciclib in HR+HER2- advanced breast cancer (ABC)ESMO Open · 2026
19. Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapyBlood · 2026
20. 443P Assessment of maintenance by endocrine therapies for metastatic breast cancer in a multicenter national observational studyESMO Open · 2026